Research comparison
A side-by-side comparison of AOD9604 and 5-Amino-1MQ as they are characterised in the peer-reviewed research literature. Metabolic small-molecule research. Both compounds are supplied for in-vitro laboratory research only.
| AOD9604 | 5-Amino-1MQ | |
|---|---|---|
| Research area | Metabolic Research | Metabolic Research |
| Sizes stocked | 2mg, 5mg, 10mg | 5mg, 10mg, 50mg |
| Reference | Full AOD9604 page → | Full 5-Amino-1MQ page → |
AOD9604 is a synthetic 16-amino-acid peptide corresponding to residues 176-191 of the C-terminus of the growth-hormone polypeptide, closed with a disulfide bond. Characterised in preclinical literature for its effects on lipolysis pathways in cultured adipocyte models. Supplied as lyophilised powder for in-vitro research use only.
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule research compound characterised in preclinical literature as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). Supplied for in-vitro research use only.
Both compounds are characterised in the research literature within metabolic small-molecule research. Researchers typically consult the primary peer-reviewed publications for each compound before selecting one for a specific experimental protocol. The two are frequently studied in parallel and occasionally cited together in comparative pharmacology reviews.
Both AOD9604 and 5-Amino-1MQ are supplied as lyophilised powder and reconstituted with bacteriostatic water using standard laboratory technique. For full reconstitution methodology see our Research Handling Guide, or compute resulting mg/ml concentrations with the Reconstitution Volume Calculator.
Every batch of both compounds is independently HPLC-verified by Janoshik Analytical at 99%+ purity. The lab report is supplied with every order and carries a unique verification key.